Product image of Glucosio Con Sodio Cloruro Fresenius Kabi Italia (Sodium Chloride, Glucose Monohydrate) supplied by GNH India

Glucosio Con Sodio Cloruro Fresenius Kabi Italia

Active Ingredient:
Sodium Chloride, Glucose Monohydrate
Origin:
EU

Glucosio Con Sodio Cloruro Fresenius Kabi Italia (Sodium Chloride, Glucose Monohydrate)

Glucosio Con Sodio Cloruro Fresenius Kabi Italia is an intravenous solution that combines sodium chloride and glucose monohydrate in a sterile solution for injection. The product is supplied without a specified concentration, conforming to EU pharmaceutical standards. It is classified as an IV electrolyte and carbohydrate solution and is available by prescription only. The formulation is intended for infusion into the bloodstream under medical supervision.

Manufacturer / TM Owner

Fresenius Kabi Italia S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosio Con Sodio Cloruro Fresenius Kabi Italia is indicated for several therapeutic situations that require isotonic fluid and carbohydrate support.

  • Replacement of extracellular fluid losses in dehydration or hemorrhage.
  • Maintenance of hydration and electrolyte balance after surgery.
  • Support of plasma osmolarity in critically ill patients.
  • Provision of glucose for patients at risk of hypoglycemia.
  • Adjunct therapy during parenteral nutrition when additional electrolytes are needed.
  • Facilitation of drug dilution for intravenous administration when compatible.

Side Effects

The safety profile of Glucosio Con Sodio Cloruro Fresenius Kabi Italia reflects the expected effects of isotonic saline and glucose solutions administered intravenously.

Common

  • Mild irritation at the infusion site.
  • Transient increase in blood glucose levels.
  • Slight electrolyte shifts causing temporary nausea.
  • Headache.
  • Dizziness.

Serious

  • Hypernatremia or severe electrolyte imbalance.
  • Hyperglycemia leading to osmotic diuresis.
  • Fluid overload with pulmonary edema.
  • Anaphylactic reaction to excipients.
  • Severe metabolic acidosis in susceptible patients.

Precautions & Warnings

When prescribing Glucosio Con Sodio Cloruro Fresenius Kabi Italia, clinicians should consider patient-specific factors and monitor relevant parameters.

  • Assess baseline serum electrolytes and glucose before infusion.
  • Adjust infusion rate in patients with renal or cardiac impairment.
  • Avoid rapid administration in neonates and infants.
  • Monitor for signs of fluid overload during prolonged therapy.
  • Use aseptic technique to prevent catheter‑related infections.
  • Re‑evaluate electrolyte status regularly during treatment.

Avoid Interactions

Glucosio Con Sodio Cloruro Fresenius Kabi Italia may interact with other intravenous or oral agents that affect fluid, electrolyte, or glucose balance.

Avoid

  • Concurrent high‑dose potassium chloride solutions without monitoring.
  • Co‑administration with hypertonic glucose preparations.

Use with caution

  • Diabetic medications (insulin, oral hypoglycemics) – monitor blood glucose.
  • Loop diuretics – risk of electrolyte depletion.
  • ACE inhibitors or ARBs – potential for altered renal handling of sodium.
  • Blood products – ensure compatible infusion rates.
  • Corticosteroids – may exacerbate hyperglycemia.

Frequently Asked Questions

The product contains sodium chloride and glucose monohydrate dissolved in a sterile aqueous solution for injection.

It is given intravenously, typically via a controlled infusion pump or gravity drip, under medical supervision.

It is used for fluid and electrolyte replacement, postoperative hydration, critical‑care volume expansion, and as an energy source for patients at risk of hypoglycemia.

Clinicians should monitor serum electrolytes, blood glucose, fluid balance, and signs of overload or adverse reactions throughout the infusion.

Use in neonates and infants is permitted only with adjusted dosing and infusion rates, and under close observation.

Common side effects include mild infusion‑site irritation, transient hyperglycemia, nausea, headache, and dizziness.

The infusion should be halted if signs of severe electrolyte imbalance, hyperglycemia, fluid overload, or anaphylaxis develop.

The glucose component can raise blood glucose temporarily; patients with diabetes may require additional monitoring and insulin adjustment.

Patients with severe heart failure should receive the solution cautiously, with reduced infusion rates and close monitoring for fluid overload.

Blood glucose should be checked frequently, and insulin doses may need adjustment to avoid hypoglycemia or hyperglycemia.

Store the unopened vials or bags in a cool, dry place, protected from light, and discard after the labeled expiration date.

Compatibility depends on the specific drug; consult compatibility charts and avoid mixing with hypertonic solutions unless verified.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Chloride, Glucose Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT